096760.KS
JW Holdings Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 4,180.00
+0.00%Margins
Gross margin
49.9%
EBITDA margin
14.8%
EBIT margin
18.8%
Net margin
8.4%
FCF margin
16.7%
29.1%
Return on equity
6.6%
Return on assets
29.4%
Return on invested capital
0.80x
Asset turnover
KRW 208.0B
Cash from operations
KRW 1.5K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026